Alterations in adenylyl cyclase sensitivity to hormones in the brain, myocardium, and testes of rats immunized with BSA-conjugated peptide 269–280 of type 3 melanocortin receptor

作者: A. O. Shpakov , K. V. Derkach , O. A. Zharova , E. A. Shpakova , V. M. Bondareva

DOI: 10.1134/S1990747815010079

关键词:

摘要: Binding of the type 3 melanocortin receptors (M3R) functionally coupled to Gs proteins with α-melanocyte-stimulating hormone (α-MSH) or M3R agonist γ-MSH results in activation adenylyl cyclase (AC) brain, which is responsible for M3R-mediated regulation physiological and biochemical processes central peripheral nervous systems. A decrease activity leads energy metabolism disorders, metabolic syndrome, functional disturbances cardiovascular However, molecular mechanisms these alterations role signaling system (ACSS) are yet poorly understood. The aim this work was study effects a long-term (13 months, 8 injections) immunization male rats BSA-conjugated peptide A-[PTNPYCICTTAH269–280]-A (A-[269–280]-A), corresponding third extracellular loop rat M3R, on ACSS its by neurotransmitters hormones testes, myocardium. At end experiment, body weight animals decreased, specific mass adipose tissue increased, dyslipidemia observed, sensitivity insulin reduced spite increase secretion response glycemic load. In brain immunized rats, AC-stimulating γ-MSH, noradrenaline, serotonin PACAP-38 stimulating effect dopamine AC-inhibiting 5-nonyloxytryptamine (an 5-hydroxytryptamine receptor (5-HTR) 1B/1D subtype) while M3R/M4R α-MSH M4R THIQ remained unchanged. myocardial membranes, stimulation AC agonists β3-adrenergic (β3-AR) enhanced, β1- β2-agonists were attenuated relaxin weakened. testicular chorionic gonadotropin as well GppNHp (non-hydrolysable GTP analog). These data indicate that attenuation considerable playing key functioning nervous, reproductive observed myocardium testes characterized hormonal specificity. Identification disorders one approaches studying etiology pathogenesis diseases associated inhibition M3R-melanocortin brain.

参考文章(47)
Airu S. Chen, Donald J. Marsh, Myrna E. Trumbauer, Easter G. Frazier, Xiao-Ming Guan, Hong Yu, Charles I. Rosenblum, Aurawan Vongs, Yue Feng, Linhai Cao, Joseph M. Metzger, Alison M. Strack, Ramon E. Camacho, Theodore N. Mellin, Christian N. Nunes, William Min, Jill Fisher, Shobhna Gopal-Truter, D. Euan MacIntyre, Howard Y. Chen, Lex H.T. Van der Ploeg, Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nature Genetics. ,vol. 26, pp. 97- 102 ,(2000) , 10.1038/79254
Alexander Shpakov, Oksana Chistyakova, Kira Derkach, Vera Bondarev, Hormonal Signaling Systems of the Brain in Diabetes Mellitus InTech. ,(2011) , 10.5772/28930
Peng Li, Bai‐Ping Cui, Ling‐Li Zhang, Hai‐Jian Sun, Tong‐Yan Liu, Guo‐Qing Zhu, None, Melanocortin 3/4 receptors in paraventricular nucleus modulate sympathetic outflow and blood pressure Experimental Physiology. ,vol. 98, pp. 435- 443 ,(2013) , 10.1113/EXPPHYSIOL.2012.067256
Yong Xu, Joel K. Elmquist, Makoto Fukuda, Central nervous control of energy and glucose balance: focus on the central melanocortin system Annals of the New York Academy of Sciences. ,vol. 1243, pp. 1- 14 ,(2011) , 10.1111/J.1749-6632.2011.06248.X
Dirk H.G. Versteeg, Patricia Van Bergen, Roger A.H. Adan, Dick J. De Wildt, Melanocortins and cardiovascular regulation. European Journal of Pharmacology. ,vol. 360, pp. 1- 14 ,(1998) , 10.1016/S0014-2999(98)00615-3
Salvatore Guarini, Helgi Schiöth, Chiara Mioni, Maria Cainazzo, Giuseppe Ferrazza, Daniela Giuliani, Jarl Wikberg, Alfio Bertolini, Carla Bazzani, MC3 receptors are involved in the protective effect of melanocortins in myocardial ischemia/reperfusion-induced arrhythmias Naunyn-schmiedebergs Archives of Pharmacology. ,vol. 366, pp. 177- 182 ,(2002) , 10.1007/S00210-002-0572-8
Jencia Wong, Nora L. Nock, Zhiying Xu, Cam Kyle, Andre Daniels, Marie White, Dennis K. Yue, Robert C. Elston, Kathleen G. Mountjoy, A polymorphism (D20S32e) close to the human melanocortin receptor 3 is associated with insulin resistance but not the metabolic syndrome. Diabetes Research and Clinical Practice. ,vol. 80, pp. 203- 207 ,(2008) , 10.1016/J.DIABRES.2007.11.002